Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactoferrin Supplementation in Preterm Newborns
NCT01172236Phase 4Completed
- Sponsor
- Università di Siena
- Start
- Jan 2011
- Primary completion
- Jan 2012
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 4, randomised, open-label trial of lactoferrin in Prematurity (PTB) and low birth weight (LBW) (2 arms), sponsored by Università di Siena. Primary endpoint: Neuro-developmental follow-up at 12 months. Started Jan 2011; status: completed.
02
Drugs
lactoferrin
03
Conditions
Prematurity (PTB)low birth weight (LBW)
Beyond the preview
Go deeper on NCT01172236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01172236.